“동래핸플🐖 ┵OPdal020.COM〉오피달리기 🏵동래아로마🍚동래풀싸롱🎮동래안마👔동래스파👅동래건마🍱동래출장안마🐪”的搜索结果，显示 201-210 项，共有 17377 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with Cemiplimab.

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer. A ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

6. 神经外科- 临床试验- 妙佑医疗国际

   了解神经外科医生如何使用清醒脑部手术和微创脊柱手术等先进技术帮助复杂疾病患者。

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...